| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics |
Natural Products Program, Cancer Research Center of Hawaii, University of Hawaii at Manoa, Honolulu, Hawaii 96813 [S. L. M., G. T., A. H. H.], and Department of Chemistry and Biochemistry, Utah State University, Logan, Utah 84322-0300 [A. P., B. S. D.]
A mechanism-based screening program aimed at the discovery of new antimicrotubule agents from natural products yielded laulimalide and isolaulimalide, two compounds with paclitaxel-like microtubule-stabilizing activity. Treatment of A-10 cells with laulimalide resulted in a dose-dependent reorganization of the cellular microtubule network and the formation of microtubule bundles and abnormal mitotic spindles. Coincident with the microtubule changes, these two compounds induced nuclear convolution and the formation of multiple micronuclei. Laulimalide is a potent inhibitor of cellular proliferation with IC50 values in the low nanomolar range, whereas isolaulimalide is much less potent with IC50 values in the low micromolar range. In contrast to paclitaxel, both laulimalide and isolaulimalide inhibited the proliferation of SKVLB-1 cells, a P-glycoprotein overexpressing multidrug-resistant cell line, suggesting that they are poor substrates for transport by P-glycoprotein. Incubation of MDA-MB-435 cells with laulimalide resulted in mitotic arrest and activation of the caspase cascade of proteolytic enzymes that accompany apoptotic cell death. Laulimalide stimulated tubulin polymerization and, although less potent than paclitaxel, it was more effective. Laulimalide-induced tubulin polymers resembled paclitaxel-induced polymers, although the laulimalide-induced polymers appeared notably longer. Laulimalide and isolaulimalide represent a new class of microtubule-stabilizing agents with activities that may provide therapeutic utility.
This article has been cited by other articles:
|
|
 |
|
  E. A. Dubikovskaya, S. H. Thorne, T. H. Pillow, C. H. Contag, and P. A. Wender Overcoming multidrug resistance of small-molecule therapeutics through conjugation with releasable octaarginine transporters PNAS, August 26, 2008; 105(34): 12128 - 12133. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. G I Kingston Tubulin-Interactive Natural Products as Anticancer Agents Am. Assoc. Cancer Res. Educ. Book, April 12, 2008; 2008(1): 305 - 313. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. F. Beyer, N. Zhang, R. Hernandez, D. Vitale, J. Lucas, T. Nguyen, C. Discafani, S. Ayral-Kaloustian, and J. J. Gibbons TTI-237: A Novel Microtubule-Active Compound with In vivo Antitumor Activity Cancer Res., April 1, 2008; 68(7): 2292 - 2300. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. S. Raccor, A. Vogt, R. P. Sikorski, C. Madiraju, R. Balachandran, K. Montgomery, Y. Shin, Y. Fukui, W.-H. Jung, D. P. Curran, et al. Cell-Based and Biochemical Structure-Activity Analyses of Analogs of the Microtubule Stabilizer Dictyostatin Mol. Pharmacol., March 1, 2008; 73(3): 718 - 726. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Hamel, B. W. Day, J. H. Miller, M. K. Jung, P. T. Northcote, A. K. Ghosh, D. P. Curran, M. Cushman, K. C. Nicolaou, I. Paterson, et al. Synergistic Effects of Peloruside A and Laulimalide with Taxoid Site Drugs, but Not with Each Other, on Tubulin Assembly Mol. Pharmacol., November 1, 2006; 70(5): 1555 - 1564. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Lu, J. Murtagh, and E. L. Schwartz The Microtubule Binding Drug Laulimalide Inhibits Vascular Endothelial Growth Factor-Induced Human Endothelial Cell Migration and Is Synergistic when Combined with Docetaxel (Taxotere) Mol. Pharmacol., April 1, 2006; 69(4): 1207 - 1215. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-C. Chou, H. Dong, X. Zhang, W. P. Tong, and S. J. Danishefsky Therapeutic Cure against Human Tumor Xenografts in Nude Mice by a Microtubule Stabilization Agent, Fludelone, via Parenteral or Oral Route Cancer Res., October 15, 2005; 65(20): 9445 - 9454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. N. Gaitanos, R. M. Buey, J. F. Diaz, P. T. Northcote, P. Teesdale-Spittle, J. M. Andreu, and J. H. Miller Peloruside A Does Not Bind to the Taxoid Site on {beta}-Tubulin and Retains Its Activity in Multidrug-Resistant Cell Lines Cancer Res., August 1, 2004; 64(15): 5063 - 5067. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Gapud, R. Bai, A. K. Ghosh, and E. Hamel Laulimalide and Paclitaxel: A Comparison of Their Effects on Tubulin Assembly and Their Synergistic Action When Present Simultaneously Mol. Pharmacol., July 1, 2004; 66(1): 113 - 121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Mooberry, D. A. Randall-Hlubek, R. M. Leal, S. G. Hegde, R. D. Hubbard, L. Zhang, and P. A. Wender From the Cover: Microtubule-stabilizing agents based on designed laulimalide analogues PNAS, June 8, 2004; 101(23): 8803 - 8808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Sampath, C. M. Discafani, F. Loganzo, C. Beyer, H. Liu, X. Tan, S. Musto, T. Annable, P. Gallagher, C. Rios, et al. MAC-321, a novel taxane with greater efficacy than paclitaxel and docetaxel in vitro and in vivo Mol. Cancer Ther., September 1, 2003; 2(9): 873 - 884. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L. Tinley, D. A. Randall-Hlubek, R. M. Leal, E. M. Jackson, J. W. Cessac, J. C. Quada Jr., T. K. Hemscheidt, and S. L. Mooberry Taccalonolides E and A: Plant-derived Steroids with Microtubule-stabilizing Activity Cancer Res., June 15, 2003; 63(12): 3211 - 3220. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Diaz, I. Barasoain, and J. M. Andreu Fast Kinetics of Taxol Binding to Microtubules. EFFECTS OF SOLUTION VARIABLES AND MICROTUBULE-ASSOCIATED PROTEINS J. Biol. Chem., February 28, 2003; 278(10): 8407 - 8419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-H. Ling, J.-D. Jiang, J. F. Holland, and R. Perez-Soler Arsenic Trioxide Produces Polymerization of Microtubules and Mitotic Arrest before Apoptosis in Human Tumor Cell Lines Mol. Pharmacol., September 1, 2002; 62(3): 529 - 538. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Hood, L. M. West, B. Rouwe, P. T. Northcote, M. V. Berridge, St. J. Wakefield, and J. H. Miller Peloruside A, a Novel Antimitotic Agent with Paclitaxel-like Microtubule- stabilizing Activity Cancer Res., June 1, 2002; 62(12): 3356 - 3360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-C. Chou, O. A. O'Connor, W. P. Tong, Y. Guan, Z.-G. Zhang, S. J. Stachel, C. Lee, and S. J. Danishefsky The synthesis, discovery, and development of a highly promising class of microtubule stabilization agents: Curative effects of desoxyepothilones B and F against human tumor xenografts in nude mice PNAS, July 3, 2001; 98(14): 8113 - 8118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Roberge, B. Cinel, H. J. Anderson, L. Lim, X. Jiang, L. Xu, C. M. Bigg, M. T. Kelly, and R. J. Andersen Cell-based Screen for Antimitotic Agents and Identification of Analogues of Rhizoxin, Eleutherobin, and Paclitaxel in Natural Extracts Cancer Res., September 1, 2000; 60(18): 5052 - 5058. [Abstract] [Full Text]
|
|
|
|
 |
|
 N.-O. Ku, X. Zhou, D. M. Toivola, and M. B. Omary The cytoskeleton of digestive epithelia in health and disease Am J Physiol Gastrointest Liver Physiol, December 1, 1999; 277(6): G1108 - G1137. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
